{"id":54587,"date":"2023-09-20T10:00:30","date_gmt":"2023-09-20T10:00:30","guid":{"rendered":"https:\/\/medsname.com\/levolin-inhaler\/"},"modified":"2026-04-30T10:24:56","modified_gmt":"2026-04-30T10:24:56","slug":"levolin-inhaler","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/levolin-inhaler\/","title":{"rendered":"Levolin Inhalator"},"content":{"rendered":"
\n

\u26a1 Quick Answer \u2014 What is Levolin Inhaler?<\/h3>\n

Levolin Inhalator<\/strong> bevat levosalbutamol<\/strong> \u2014 the active R-isomer of salbutamol, a short-acting beta-2 agonist (SABA)<\/strong> that relaxes bronchial smooth muscle to relieve breathlessness, wheezing, and chest tightness in asthma<\/strong> en chronic obstructive pulmonary disease (COPD)<\/strong>. Levolin Inhaler is a pressurised metered-dose inhaler (HFA pMDI)<\/strong> van Cipla<\/strong>. Onset of bronchodilation is 1\u20135 minutes<\/strong> and effect lasts 4\u20136 uur<\/strong>. Levosalbutamol delivers similar bronchodilation to salbutamol at half the dose, with potentially fewer cardiac side-effects (tremor, tachycardia) \u2014 useful for patients sensitive to standard salbutamol.<\/p>\n<\/div>\n

\nWat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde klantbeoordelingen<\/a>\n<\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n

Waarom bestellen bij MedsBase<\/h3>\n

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n

\n\ud83d\udd12 Versleutelde afrekenprocedure<\/strong> \u00b7 \ud83d\udcb3 Geverifieerde betalingsverwerker<\/strong> \u00b7 \ud83d\ude9a Wereldwijde verzending<\/strong> \u00b7 \u2b50 4,9\/5 van 1.400+ klanten<\/strong>\n<\/div>\n

What Is Levolin Inhaler?<\/h2>\n

Levolin Inhaler is a pressurised metered-dose inhaler (HFA pMDI)<\/strong> geproduceerd door Cipla<\/strong> at WHO-GMP certified facilities. Each inhaler delivers 50 mcg per actuation<\/strong> van levosalbutamol<\/strong>. levosalbutamol is on the WHO List of Essential Medicines<\/strong> and is the world’s most-used reliever medication for asthma and reversible airflow obstruction.<\/p>\n

Levosalbutamol is the pharmacologically active R-(\u2212)-enantiomer<\/strong> of salbutamol. Standard salbutamol is a 50:50 racemic mixture of R and S isomers; the S-isomer contributes nothing to bronchodilation but may worsen airway hyperreactivity in some patients. By using only the R-isomer, levosalbutamol delivers the same therapeutic effect at half the milligram dose<\/strong>, with potentially less tremor and tachycardia in sensitive patients (especially children and those with cardiovascular comorbidities).<\/p>\n

How Does Levolin Inhaler Work?<\/h2>\n

levosalbutamol selectively activates beta-2 adrenergic receptors<\/strong> on the smooth muscle that rings the bronchial airways. Receptor activation raises intracellular cyclic AMP, smooth muscle relaxes, and the airway lumen widens \u2014 this is bronchodilation<\/strong>. Bronchodilation begins within 1\u20135 minutes<\/strong>, peaks at 30\u201390 minutes, and lasts 4\u20136 uur<\/strong>. levosalbutamol also modestly inhibits mast-cell mediator release, reduces plasma exudation from airway capillaries, and improves mucociliary clearance.<\/p>\n

Selectivity is dose-dependent: at therapeutic doses, \u03b22 effects predominate; at higher systemic doses (oral tablets, repeated nebulisation), spillover onto \u03b21 receptors causes tachycardia and palpitations, and onto \u03b22 receptors elsewhere causes tremor and hypokalaemia.<\/p>\n

Toepassingen en Indicaties<\/h2>\n